← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Anacor Pharmaceuticals, Inc.
Palo Alto, CA
$1,765,238
Total funding
4
Grants
Funding over time
peak $1.2M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
DOD$1,140,956 · 3
NIH$624,282 · 1
By mechanism
—$1,140,956 · 3
R01$624,282 · 1
Investigators at Anacor Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
ANTIFUNGAL AGENT TARGET IDENTIFICATION: SYNTHETIC CHEMISTRY$624,282
R01 · FY2005 · DE
Target Identification of a Novel Antifungal Agent$624,282
R01 · FY2005 · DE
DEVELOPMENT OF NOVEL RHO KINASE INHIBITORS FOR TREATMENT OF PULMONARY HYPERTENSION$519,575
· FY2014 · Department of Defense
NOVEL OXABOROLE ANALOGS FOR TREATMENT OF CUTANEOUS LEISHMANIASIS$473,020
· FY2014 · Department of the Army
Target Identification of a Novel Antifungal Agent$405,130
R01 · FY2006 · DE
TRANSLATION OF NOVEL PDE4 INHIBITORS FOR THE TREATMENT OF ACUTE SPINAL CORD INJURY (SCI)$148,361
· FY2011 · Department of Defense